Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-23,000
Closed -$1.4M 7363
2017
Q1
$1.4M Buy
+23,000
New +$1.38M ﹤0.01% 2849
2016
Q4
Sell
-10,500
Closed -$607K 7203
2016
Q3
$607K Buy
+10,500
New +$618K ﹤0.01% 3719
2014
Q1
Sell
-400
Closed -$16K 7049
2013
Q4
$16K Sell
400
-4,000
-91% -$157K ﹤0.01% 6244
2013
Q3
$161K Buy
4,400
+2,400
+120% +$90.7K ﹤0.01% 4345
2013
Q2
$74K Buy
+2,000
New +$71.4K ﹤0.01% 5093

Other funds holding DOX

Citigroup's DOX Position: Q2 2026 in Review

Citigroup increased its Amdocs (DOX) stake by 396% in Q2 2026, buying an estimated $21.1M and bringing the position to 430,472 shares worth $21.8M. The position accounts for 0.01% of the portfolio, ranked #1129.

Citigroup first reported a position in DOX in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.4M in Q4 2019. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Citigroup held 430,472 shares of Amdocs worth $21.8M as of Q2 2026.
  • Citigroup bought 343,740 Amdocs shares in Q2 2026, an estimated $21.1M.
  • Amdocs made up 0.01% of Citigroup's portfolio in Q2 2026, its #1129 holding.
  • Citigroup first reported a position in Amdocs in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Amdocs position peaked at $37.4M in Q4 2019.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.